- Breast cancer
Lawrence N. Shulman, MD
About me
- Director, Center for Global Cancer Medicine, Abramson Cancer Center
- Emeritus Professor CE of Medicine (Hematology-Oncology)
My education and training
- Medical School: Harvard Medical School
- Residency: Beth Israel Deaconess Medical Center
- Fellowship: Beth Israel Deaconess Medical Center
Spoken languages
Reviews
62 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Qualifications and experience
- Hematology, 1982
- Medical Oncology, 1981
- Internal Medicine, 1978
- American College of Physicians, National
- American Society of Clinical Oncology, National
- ASCP Partners for Cancer Diagnosis and Treatment Initiative Advisory Committee, National
- Breast Health Global Initiative, Steering Committee, International
- Global Oncology, International
- National Cancer Policy Forum, National
- National Research Council, National
- NCCN Best Practices Committee, National
- Partners In Health, International
- The Max Foundation, National
Treatments and conditions
Research
Publications
Herbst RS, Blumenthal G, Khleif SN, Lippman SM, Meropol NJ, Rosati K, Shulman LN, Smith H, Wang M, Winn RA, Schilsky RL. Optimizing public-private partnerships to support clinical cancer research , J Natl Cancer Inst. Dec 12:djae279. doi: 10.1093/jnci/djae279, 117: 2025,1305-1310
Shulman LN, Hricak H, Eckhardt SG. Challenges and Opportunities for the US Oncology Workforce , JAMA Oncol. doi:10.1001/jamaoncol.2025.2331: 2025
Shulman LN, Bradley CJ, Winn RA, Yabroff KR. Cancer Surveillance in the United States in Jeopardy: Leveraging 21st Century Technology to Enhance Public Health , J Clin Oncol. doi: 10.1200/JCO-25-0075: 2025
Bhangdia K, Natarajan A, Rudolfson N, Verguet S, Castro MC, Dusengimana JV, Shyirambere C, Schleimer LE, Shulman LN, Umwizerwa A, Kigonya C, Butonzi J, MacDuffie E, Fadelu T, O'Neil DS, Nguyen C, Mpunga T, Keating NL, Pace LE. The association of travel distance and other patient characteristics with breast cancer stage at diagnosis and treatment completion at a rural Rwandan cancer facility , BMC Cancer. doi: 10.1186/s12885-025-13489-2. , 25: 2025,146
Bange EM, Coughlin KQ, Li W, Brown TJ, Ragusano D, Balar E, Arasappan D, Nnaji M, Kim E, Alban C, Uppuluri S, Moriarty E, Bange T, Zinck L, Smith D, Josephs M, Harrigan JJ, Cohen RB, Zubka D, Rosin R, Balachandran M, Long Q, Bilger A, Schuchter LM, Mamtani M, Shulman LN, Guerra CE, Mamtani R. A Text Message Intervention to Minimize the Time Burden of Cancer Care , NEJM Catal Innov Care Deliv. doi:10.1056/CAT.24.0201.: 2025
Desai AN, Jacobs E, Ogedegbe O, Rubenfeld G, Berlin J, Shulman L, O'Cearbhaill R, Studenski S, Powell E, Mmeje O, Trueger NS, Chino F, Perlis R, Fihn S, Perencevich E. The Global Public Health Imperative-Where Do We Go From Here? , JAMA Netw Open. 2025 May 1;8(5):e2517283. doi:10.1001/jamanetworkopen.2025: 2025
Martei YM, Gurram M, Mokokwe LT, Ngwako N, Kebuang K, Setlhako DI, Vuylsteke P, Bontswanetse B, Segadimo T, Mosepele M, Shulman LN, Barg F, Gaolebale BE. Baseline Distress and Effectiveness of Survivor Video Narratives on Cancer-Associated Distress in Botswana: A Pilot Study , JCO Glob Oncol. doi: 10.1200/GO-24-00474: 2025
Schnoll R, Bekelman JE, Blumenthal D, Asch DA, Buttenheim AM, Chaiyachati KH, Domchek SM, Fayanju OM, Gabriel P, Jenssen BP, Leone FT, McCarthy AM, Nathanson KL, Parikh RB, Rendle KA, Shelton RC, Shulman LN, Takvorian SU, Ware S, Wileyto EP, Beidas RS. Using the Translational Science Benefits Model to assess the impact of the Penn Implementation Science Center in Cancer Control , J Clin Transl Sci. doi:10.1017/cts.2024.554., 8: 2024,e166
Castillo BS, Boadi T, Han X, Shulman LN, Martei YM. Racial Disparities in Receipt of Guideline-Concordant Care in Older Adults With Early Breast Cancer , JAMA Netw Open, 7: 2024,e2441056
Jacobs L, Shulman L Cardio-Oncology Care Delivery for All Patients With Cancer Within Academic and Community Settings. , J Am Coll Cardiol CardioOnc. 2024, 0 (0) doi: 10.1016/j.jaccao.2023.10.010: 2024